New Data Show Majority of Adults with Moderate to Severe Plaque Psoriasis Treated with First-in-Class TREMFYA® (guselkumab) Experienced Durable Skin Clearance Through Five Years Regardless of Metabolic Syndrome Status, Baseline Disease Severity, or Treatment History
Put up hoc evaluation exhibits TREMFYA responders reported clinically vital enhancements throughout measures of social and sexual operate and fatigue ...
